DCL-101

EU Patent Granted to Dark Canyon Labs

Dark Canyon Labs was notified of intention to grant European Union Patent No. EP2421373 for development of a novel Colon Lavage System on April 15, 2019.

Dark Canyon Labs is especially pleased to announce that this EU Patent for DCL-101, a novel taste-free pill prep, used for colonoscopy preparation, joins patents for DCL-101 already issued in the US, Japan, Australia, Canada, and China. Patent is pending in Hong Kong.

Phase 2 Results of Dark Canyon Labs' Novel Pill Prep DCL-101 Selected as one of the "Most Innovative and Impactful Abstracts at ACG 2018"

The American College of Gastroenterology’s (ACG) Innovation & Technology Committee recently selected 22 abstracts as the “Most Innovative and Impactful Abstracts at ACG 2018”, from over 2600 abstracts that were presented at the ACG’s annual Scientific Meeting in Philadelphia, PA in October 2018.

Dark Canyon Labs’ presentation of Phase 2 study results of the Novel Pill Prep, DCL-101, was selected as one of the “Most Innovative and Impactful Abstracts at ACG 2018.”

The ACG Innovation & Technology Committee is a forum that allows members to gather information about new ideas, innovations and technologies in gastroenterology. Selecting the “Most Innovative and Impactful Abstracts at ACG 2018” allowed the Committee to highlight the clinical significance and importance of emerging technologies in gastroenterology.

See the complete ACG report here.

Dark Canyon Labs announces completion of Phase 2 Clinical Trial

Dark Canyon Labs is pleased to announce the completion of a multicenter, randomized, investigator blinded, non-inferiority Phase 2 Clinical Trial.  DCL-101, a novel Pill Prep, was compared to standard split-dose GoLYTELY® in adult outpatients undergoing routine colonoscopy.

Based on tolerability, safety, and efficacy results, Dark Canyon Labs is excited to announce that DCL-101 will move ahead for further evaluation in two definitive Phase 3 trials.  

Watch for additional details soon. For more information, contact darkcanyonlabs@me.com